Loading data
BCRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 19.08 m USD | 12.27 m USD | 4.48 m USD | 6.41 m USD | 7.23 m USD |
| Research and development expense | 166.13 m USD | 174.64 m USD | 216.57 m USD | 253.3 m USD | 208.81 m USD |
| Selling, general and administrative expense | 348.65 m USD | 266.35 m USD | 214.07 m USD | 159.37 m USD | 118.82 m USD |
| Operating profit | 340.99 m USD | -2.54 m USD | -103.71 m USD | -148.44 m USD | -177.72 m USD |
| Interest expense | — | — | 108.24 m USD | 99.09 m USD | 59.29 m USD |
| Profit before tax | 267.39 m USD | -86.95 m USD | -226.23 m USD | -244.38 m USD | -181.81 m USD |
| Income tax expense | 3.53 m USD | 1.93 m USD | 310 k USD | 2.73 m USD | 2.25 m USD |
| Net income (reported basis) | 263.86 m USD | -88.88 m USD | -226.54 m USD | -247.12 m USD | -184.06 m USD |
| Basic earnings per share | 1.26 USD/share | -0.43 USD/share | -1.18 USD/share | -1.33 USD/share | -1.03 USD/share |
| Diluted earnings per share | 1.21 USD/share | -0.43 USD/share | -1.18 USD/share | -1.33 USD/share | -1.03 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.